Home Imidazoles 274-49-7
274-49-7,MFCD09263928
Catalog No.:AA007KS7
274-49-7 | Imidazo[1,5-a]pyrazine
Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$72.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA007KS7
Chemical Name:
Imidazo[1,5-a]pyrazine
CAS Number:
274-49-7
Molecular Formula:
C6H5N3
Molecular Weight:
119.1240
MDL Number:
MFCD09263928
IUPAC Name:
imidazo[1,5-a]pyrazine
InChI:
InChI=1S/C6H5N3/c1-2-9-5-8-4-6(9)3-7-1/h1-5H
InChI Key:
MIFJMFOVENWQDP-UHFFFAOYSA-N
SMILES:
n1ccn2c(c1)cnc2
NSC Number:
157973
Properties
Computed Properties
 
Complexity:
105  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
119.048g/mol
Formal Charge:
0
Heavy Atom Count:
9  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
119.127g/mol
Monoisotopic Mass:
119.048g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
30.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.8  

Synonyms
 
imidazo(1,5-a)pyrazine 
Imidazo[1,5-a]pyrazine 
DTXSID30303354 
KS-00000P9H 
ZINC1601710 
ACM274497 
FCH868057 
MFCD09263928 
AKOS006329947 
NSC-157973 
AJ-28001 
DS-15237 
274-49-7 
AX8219325 
A819139 
AR-1J2239 
CID292283 
27618-25-3 
imidazo(1,5-a)pyrazine 
AK-72743 
NSC157973 
AC1L6HO9 
AC1Q4YE6 
SCHEMBL869469 
CTK1A7569 
Literature

Title: Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479.

Journal: Bioorganic & medicinal chemistry letters 20141001

Title: Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.

Journal: European journal of medicinal chemistry 20110601

Title: Imidazo[1,5-a]pyrazines: orally efficacious inhibitors of mTORC1 and mTORC2.

Journal: Bioorganic & medicinal chemistry letters 20110401

Title: Synthesis of substituted imidazo[1,5-a]pyrazines via mono-, di-, and directed remote metalation strategies.

Journal: Organic letters 20091119

Title: Kinase inhibitors for the treatment of inflammatory and autoimmune disorders.

Journal: Purinergic signalling 20090301

Title: A novel synthesis of highly substituted imidazo[1,5-a]pyrazine derivatives by 3-CR/2-CR sequence.

Journal: Molecular diversity 20090201

Title: Palladium-catalyzed direct heck arylation of dual pi-deficient/pi-excessive heteroaromatics. Synthesis of C-5 arylated imidazo[1,5-a]pyrazines.

Journal: Organic letters 20080717

Title: Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors.

Journal: Bioorganic & medicinal chemistry 20080201

Title: Synthesis and c-Src inhibitory activity of imidazo[1,5-a]pyrazine derivatives as an agent for treatment of acute ischemic stroke.

Journal: Bioorganic & medicinal chemistry 20070115

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Additional Info:
Related Products